Significant Ownership of Point72 Asset Management, L.P.

Notable people
Steven A. Cohen
Signature - Title
/s/ Jason M. Colombo - Jason M. Colombo, Authorized Person
Location
Stamford, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Point72 Asset Management, L.P..

Notify me when Point72 Asset Management, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Point72 Asset Management, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CCCC C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $50,277,776 22,647,647 Point72 Asset Management, L.P. 17 Oct 2025
CYBN CYBIN INC. Common Shares, no par value 9.9% $37,759,482 +$28,298,275 6,410,778 +299% Point72 Asset Management, L.P. 30 Sep 2025
PTNT PALATIN TECHNOLOGIES INC Common Stock, par value $0.01 per share 9.9% $23,646,750 2,307,000 Point72 Asset Management, L.P. 12 Nov 2025
IBIO iBio, Inc. Common Stock, par value $0.001 per share 9.9% $9,716,600 14,289,118 Point72 Asset Management, L.P. 22 Aug 2025
QTTB Q32 Bio Inc. Common Stock, par value $0.0001 per share 9.9% $8,085,220 2,057,308 Point72 Asset Management, L.P. 17 Feb 2026
XLO Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.9% $6,743,200 +$3,371,600 8,000,000 +100% Point72 Asset Management, L.P. 30 Sep 2025
DSGN Design Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.4% $50,443,118 +$22,810,986 5,372,004 +83% Point72 Asset Management, L.P. 31 Dec 2025
TNXP Tonix Pharmaceuticals Holding Corp. Common Stock, par value $0.001 per share 9.2% $19,884,434 1,235,058 Point72 Asset Management, L.P. 29 Dec 2025
ANRO Alto Neuroscience, Inc. Common Stock, par value $0.0001 per share 8.9% $46,600,538 +$15,121,326 2,824,275 +48% Steven A. Cohen 31 Dec 2025
ONCH 1RT Acquisition Corp. Class A Ordinary Shares, par value $0.0001 per share 8.7% 1,500,000 Point72 Asset Management, L.P. 03 Jul 2025
OKYO OKYO Pharma Ltd Ordinary Shares, no par value 7.9% $8,279,228 4,058,445 Point72 Asset Management, L.P. 17 Feb 2026
RLAY Relay Therapeutics, Inc. Common Stock, par value $0.001 per share 7.8% $50,152,476 +$13,993,047 13,445,704 +39% Point72 Asset Management, L.P. 30 Jun 2025
ANAB ANAPTYSBIO, INC Common Stock, par value $0.001 per share 7.7% $49,025,259 +$14,013,859 2,368,370 +40% Point72 Asset Management, L.P. 31 Mar 2025
ZEPP Zepp Health Corp Class A Ordinary Shares, par value $0.0001 per share 7.6% $401,805,282 +$105,511,398 8,777,008 +36% Point72 Asset Management, L.P. 30 Sep 2025
EDSA Edesa Biotech, Inc. Common Shares, without par value 7.2% $588,000 600,000 Point72 Asset Management, L.P. 24 Feb 2026
PALI PALISADE BIO, INC. Common Stock, par value $0.01 per share 7% $20,150,884 +$5,586,511 10,495,252 +38% Point72 Asset Management, L.P. 31 Dec 2025
DNTH Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share 6.9% $107,936,599 +$31,151,331 2,981,674 +41% Point72 Asset Management, L.P. 31 Dec 2025
IPSC Century Therapeutics, Inc. Common Stock, par value $0.0001 per share 6.8% $12,817,360 5,961,563 Point72 Asset Management, L.P. 23 Dec 2025
TENX TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 6.8% $6,372,396 +$1,260,919 423,415 +25% Point72 Asset Management, L.P. 31 Dec 2025
CLDX Celldex Therapeutics, Inc. Common Stock, par value $0.001 per share 6.7% $90,854,558 4,464,400 Point72 Asset Management, L.P. 02 Jul 2025
FBRX Forte Biosciences, Inc. Common Stock, par value $0.001 per share 6.3% $21,132,810 792,976 Point72 Asset Management, L.P. 12 Jan 2026
GLTO Galecto, Inc. Common Stock, par value $0.00001 per share 6.3% $372,164 100,001 Point72 Asset Management, L.P. 12 Nov 2025
ANGO ANGIODYNAMICS INC Common Stock, par value $0.01 per share 6.2% $28,588,375 +$4,905,719 2,559,389 +21% Point72 Asset Management, L.P. 30 Sep 2025
PRAX Praxis Precision Medicines, Inc. Common Stock, par value $0.0001 per share 6.1% $452,667,181 -$145,274,958 1,569,309 -24% Steven A. Cohen 31 Dec 2025
IVVD Invivyd, Inc. Common Stock, par value $0.0001 per share 6% $41,965,651 -$9,372,996 16,653,036 -18% Point72 Asset Management, L.P. 31 Dec 2025
IMNM Immunome Inc. Common Stock, par value $0.0001 per share 5.9% $41,638,177 4,887,110 Point72 Asset Management, L.P. 31 Jan 2025
Infinite Eagle Acquisition Corp. Class A Ordinary Shares, par value $0.0001 per share 5.8% 1,760,000 Point72 Asset Management, L.P. 20 Jan 2026
IOBT IO Biotech, Inc. Common Stock, par value $0.001 per share 5.6% $2,452,108 4,027,112 Point72 Asset Management, L.P. 05 Feb 2026
MSGE Madison Square Garden Entertainment Corp. Class A Common Stock, par value $0.01 per share 5.5% $72,797,952 2,239,248 Point72 Asset Management, L.P. 31 Dec 2024
KALV KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 5.5% $44,930,777 2,781,902 Point72 Asset Management, L.P. 05 Jan 2026
BRCB Black Rock Coffee Bar, Inc. Class A Common Stock, par value $0.00001 per share 5.4% $22,629,182 948,415 Steven A. Cohen 12 Nov 2025
PGEN PRECIGEN, INC. Common Stock, no par value per share 5.2% $76,841,952 18,383,242 Point72 Asset Management, L.P. 22 Jan 2026
BBNX Beta Bionics, Inc. Common Stock, par value $0.0001 per share 5.2% $34,190,043 2,290,023 Point72 Asset Management, L.P. 18 Feb 2026
LION Lionsgate Studios Corp. Common Shares, no par value per share 5.1% $101,210,670 14,668,213 Point72 Asset Management, L.P. 31 Oct 2025
ORIC Oric Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 5.1% $23,372,809 4,401,659 Point72 Asset Management, L.P. 29 May 2025
OVID Ovid Therapeutics Inc. Common Stock, par value $0.001 per share 5.1% $11,099,895 6,727,209 Point72 Asset Management, L.P. 02 Jan 2026
VNET VNET Group, Inc. Class A Ordinary Shares, par value $0.00001 per share 5% $684,703,700 +$357,302,860 79,848,828 +109% Steven A. Cohen 08 Jan 2026
BILL BILL Holdings, Inc. Common Stock, par value $0.00001 per share 5% $247,450,711 5,035,627 Point72 Asset Management, L.P. 21 Nov 2025
RUN Sunrun Inc. Common Stock, par value $0.0001 per share 5% $78,798,749 11,503,467 Point72 Asset Management, L.P. 26 Jun 2025
SNDX Syndax Pharmaceuticals Inc Common Stock, par value $0.0001 per share 5% $44,621,185 +$20,827,520 4,327,952 +88% Point72 Asset Management, L.P. 15 Aug 2025
LENZ LENZ Therapeutics, Inc. Common Stock, par value $0.00001 per share 4.8% $63,244,042 1,357,751 Steven A. Cohen 30 Sep 2025
REPL Replimune Group, Inc. Common Stock, par value $0.001 per share 4.7% $15,209,289 -$3,488,586 3,629,902 -19% Point72 Asset Management, L.P. 30 Sep 2025
LLYVA Liberty Media Corp Series A Liberty Live Common Stock, par value $0.01 per share 4.6% $77,347,262 1,164,693 Point72 Asset Management, L.P. 31 Dec 2024
VTYX Ventyx Biosciences, Inc. Common Stock, par value $0.0001 per share 4.5% $9,981,996 -$8,351,669 3,209,645 -46% Point72 Asset Management, L.P. 30 Sep 2025
RCUS Arcus Biosciences, Inc. Common Stock, par value $0.0001 per share 4.1% $58,921,714 -$20,381,232 4,332,479 -26% Point72 Asset Management, L.P. 30 Sep 2025
COGT Cogent Biosciences, Inc. Common Stock, par value $0.001 per share 4% $82,625,042 -$60,775,814 5,753,833 -42% Point72 Asset Management, L.P. 30 Sep 2025
ADCT ADC Therapeutics SA Common Shares, par value CHF 0.08 per share 4% $18,554,083 -$10,422,190 5,014,617 -36% Point72 Asset Management, L.P. 31 Dec 2025
ALTS ALT5 Sigma Corp Common Stock, par value $0.001 per share 4% 4,872,756 Point72 Asset Management, L.P. 11 Aug 2025
STNE StoneCo Ltd. Class A Common Shares, par value US$0.000079365 per share 3.9% $154,268,604 -$64,018,202 9,972,114 -29% Point72 Asset Management, L.P. 30 Jun 2025
BCYC BICYCLE THERAPEUTICS PLC Ordinary Shares, nominal value 0.01 GBP per share 3.9% $14,882,536 -$15,032,008 1,860,317 -50% Point72 Asset Management, L.P. 30 Jun 2025
PAGS PagSeguro Digital Ltd. Class A Common Shares, par value $0.000025 per share 3.8% $57,737,749 -$40,080,797 5,989,393 -41% Point72 Asset Management, L.P. 31 Dec 2025
WOLF WOLFSPEED, INC. Common Stock, par value $0.00125 per share 3.8% $19,317,826 -$10,844,380 990,150 -36% Point72 Asset Management, L.P. 31 Dec 2025
KOD Kodiak Sciences Inc. Common Stock, par value $0.0001 per share 3.5% $58,658,768 -$20,083,422 2,166,929 -26% Point72 Asset Management, L.P. 31 Dec 2025
AVTX Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share 3.5% $10,636,159 -$7,228,853 627,502 -40% Point72 Asset Management, L.P. 31 Dec 2025
TDOC Teladoc Health, Inc. Common Stock, par value $0.001 per share 3.3% $44,796,726 -$23,430,960 5,795,178 -34% Point72 Asset Management, L.P. 30 Sep 2025
ATYR aTYR PHARMA INC Common Stock, par value $0.001 per share 3.2% $9,617,297 2,845,354 Point72 Asset Management, L.P. 31 Mar 2025
PEPG PepGen Inc. Common Stock, par value $0.0001 per share 3% $9,551,949 -$2,811,415 2,067,432 -23% Point72 Asset Management, L.P. 30 Sep 2025
DRUG BRIGHT MINDS BIOSCIENCES INC. Common Shares, without par value 3% $4,175,988 135,189 Point72 Asset Management, L.P. 31 Dec 2024
MBLY Mobileye Global Inc. Class A Common Stock, par value $0.01 per share 2.8% $84,823,217 -$3,371,672 6,007,310 -3.8% Point72 Asset Management, L.P. 30 Sep 2025
TSEM TOWER SEMICONDUCTOR LTD Ordinary Shares, par value NIS 15.00 per share 2.6% $206,369,650 -$252,010,688 2,854,352 -55% Point72 Asset Management, L.P. 30 Sep 2025
AMLX Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 2.6% $38,074,233 -$26,039,432 2,801,636 -41% Point72 Asset Management, L.P. 30 Sep 2025
ENTX Entera Bio Ltd. Ordinary shares, par value NIS 0.0000769 per share 2.6% $2,271,583 -$2,915,412 1,183,116 -56% Point72 Asset Management, L.P. 30 Sep 2025
CTMX CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share 2.5% $12,978,754 -$12,811,193 4,068,575 -50% Point72 Asset Management, L.P. 30 Sep 2025
RPD Rapid7, Inc. Common Stock, par value $0.01 per share 2.4% $36,462,076 1,502,971 Point72 Asset Management, L.P. 31 Dec 2024
OLMA Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 2.3% $7,781,412 1,543,931 Point72 Asset Management, L.P. 31 Mar 2025
IDYA IDEAYA Biosciences, Inc. Common Stock, par value $0.0001 per share 2.1% $67,953,443 -$94,600,552 1,844,556 -58% Point72 Asset Management, L.P. 31 Dec 2025
ARRY Array Technologies, Inc. Common Stock, par value $0.001 per share 2% $16,159,114 -$24,118,877 3,054,653 -60% Point72 Asset Management, L.P. 31 Mar 2025
WWW Wolverine World Wide Inc /DE/ Common Stock, par value $1 per share 1.5% $22,858,695 -$71,449,297 1,230,285 -76% Point72 Asset Management, L.P. 31 Dec 2025
DYN Dyne Therapeutics, Inc. Common Stock, par value $0.0001 per share 1.5% $18,546,390 -$39,187,803 1,669,342 -68% Point72 Asset Management, L.P. 31 Mar 2025
CDTX Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share 1.4% $99,621,000 -$249,731,915 450,000 -71% Point72 Asset Management, L.P. 31 Dec 2025
LITE Lumentum Holdings Inc. Common Stock, par value $0.001 per share 1.3% $83,269,755 -$307,562,007 895,470 -79% Point72 Asset Management, L.P. 30 Jun 2025
VSTM Verastem, Inc. Common Stock, par value $0.0001 per share 1.3% $7,681,601 -$18,090,994 995,026 -70% Point72 Asset Management, L.P. 31 Dec 2025
SPHR Sphere Entertainment Co. Class A Common Stock, par value $0.01 per share 0.8% $13,881,584 -$81,500,570 223,464 -85% Point72 Asset Management, L.P. 30 Sep 2025
RGLS Regulus Therapeutics Inc. Common Stock, par value $0.001 per share 0.3% $1,977,487 -$30,197,722 241,157 -94% Point72 Asset Management, L.P. 30 Jun 2025
CFLT Confluent, Inc. Class A Common Stock, par value $0.00001 per share 0.1% $5,589,991 -$527,903,079 183,700 -99% Point72 Asset Management, L.P. 31 Dec 2025
ANNX Annexon, Inc. Common Stock, par value $0.001 per share 0.1% $181,317 95,430 Point72 Asset Management, L.P. 31 Mar 2025
PLRX PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 0.1% $56,775 -$4,926,946 46,537 -99% Point72 Asset Management, L.P. 31 Dec 2025
WHWK Whitehawk Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $7,834 -$2,256,445 5,087 -100% Point72 Asset Management, L.P. 31 Mar 2025
KALA KALA BIO, Inc. Common Stock, par value $0.001 per share 0% $393 -$717,340 257 -100% Point72 Asset Management, L.P. 30 Sep 2025
SYRS Syros Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 0% $14.88 496 Point72 Asset Management, L.P. 31 Dec 2024
FGNX FG Nexus Inc. Common Stock, par value $0.001 per share 0% $0 -$12,960,000 0 -100% Point72 Asset Management, L.P. 31 Dec 2025
SHLS Shoals Technologies Group, Inc. Class A Common Stock, par value $0.00001 per share 0% $0 -$52,172,962 0 -100% Point72 Asset Management, L.P. 30 Jun 2025
IKT Inhibikase Therapeutics, Inc. Common Stock, par value $0.001 per share 0% $0 0 Point72 Asset Management, L.P. 31 Dec 2024
CDMO Avid Bioservices, Inc. Common Stock, par value $0.001 per share 0% $0 0 Point72 Asset Management, L.P. 31 Dec 2024
KRRO Korro Bio, Inc. Common Stock, par value $0.001 per share 0% $0 -$7,343,976 0 -100% Point72 Asset Management, L.P. 31 Dec 2025
SGMT Sagimet Biosciences Inc. Series A Common Stock, par value $0.0001 per share 0% $0 -$16,621,204 0 -100% Point72 Asset Management, L.P. 30 Jun 2025
TSBX Turnstone Biologics Corp. Common Stock, par value $0.001 per share 0% $0 0 Point72 Asset Management, L.P. 30 Sep 2025
JOYY JOYY Inc. Class A Common Shares, par value US$0.00001 per share 0% $0 0 Point72 Asset Management, L.P. 31 Mar 2025
APVO Aptevo Therapeutics Inc. Common Stock, par value $0.001 per share 0% $0 -$182,966 0 -100% Point72 Asset Management, L.P. 31 Dec 2025

Schedules 13D/G Reported by Point72 Asset Management, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.